$525 Million is the total value of Ghost Tree Capital, LLC's 52 reported holdings in Q4 2019. The portfolio turnover from Q3 2019 to Q4 2019 was 90.9% .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| SPY | Buy | SPDR S&P 500 ETF TRput | $64,372,000 | +116.9% | 200,000 | +100.0% | 12.26% | +62.1% |
| XBI | Buy | SPDR SERIES TRUSTput | $47,556,000 | +55.5% | 500,000 | +24.7% | 9.06% | +16.3% |
| ASND | Buy | ASCENDIS PHARMA A Ssponsored adr | $27,824,000 | +92.6% | 200,000 | +33.3% | 5.30% | +44.0% |
| CNST | New | CONSTELLATION PHARMCETICLS I | $27,112,000 | – | 575,500 | +100.0% | 5.16% | – |
| AXSM | Sell | AXSOME THERAPEUTICS INC | $20,672,000 | +51.3% | 200,000 | -70.4% | 3.94% | +13.1% |
| MRTX | Sell | MIRATI THERAPEUTICS INC | $19,329,000 | -9.8% | 150,000 | -45.5% | 3.68% | -32.6% |
| IOVA | Buy | IOVANCE BIOTHERAPEUTICS INC | $17,992,000 | +97.7% | 650,000 | +30.0% | 3.43% | +47.8% |
| RCKT | Buy | ROCKET PHARMACEUTICALS INC | $15,932,000 | +118.8% | 700,000 | +12.0% | 3.03% | +63.6% |
| RETA | Buy | REATA PHARMACEUTICALS INCcl a | $15,332,000 | +281.9% | 75,000 | +50.0% | 2.92% | +185.4% |
| AERI | Buy | AERIE PHARMACEUTICALS INC | $13,898,000 | +221.3% | 575,000 | +155.6% | 2.65% | +140.2% |
| ADVM | Sell | ADVERUM BIOTECHNOLOGIES INC | $13,536,000 | +71.3% | 1,175,000 | -19.0% | 2.58% | +28.1% |
| IMVT | New | IMMUNOVANT INC | $12,696,000 | – | 800,000 | +100.0% | 2.42% | – |
| FOLD | Sell | AMICUS THERAPEUTICS INC | $12,175,000 | -11.0% | 1,250,000 | -26.7% | 2.32% | -33.4% |
| AUPH | New | AURINIA PHARMACEUTICALS INC | $12,156,000 | – | 600,000 | +100.0% | 2.32% | – |
| BPMC | Sell | BLUEPRINT MEDICINES CORP | $12,017,000 | -49.7% | 150,000 | -53.8% | 2.29% | -62.4% |
| SAGE | New | SAGE THERAPEUTICS INCcall | $10,829,000 | – | 150,000 | +100.0% | 2.06% | – |
| IMMU | Sell | IMMUNOMEDICS INC | $10,580,000 | +10.0% | 500,000 | -31.0% | 2.02% | -17.7% |
| BCRX | Buy | BIOCRYST PHARMACEUTICALS | $10,350,000 | +140.8% | 3,000,000 | +100.0% | 1.97% | +80.0% |
| IOVA | New | IOVANCE BIOTHERAPEUTICS INCcall | $9,688,000 | – | 350,000 | +100.0% | 1.84% | – |
| ARVN | Buy | ARVINAS INC | $9,245,000 | +131.9% | 225,000 | +21.6% | 1.76% | +73.3% |
| APLS | New | APELLIS PHARMACEUTICALS INCput | $9,186,000 | – | 300,000 | +100.0% | 1.75% | – |
| SRPT | Sell | SAREPTA THERAPEUTICS INC | $8,388,000 | -49.4% | 65,000 | -70.5% | 1.60% | -62.2% |
| DBVT | New | DBV TECHNOLOGIES S Asponsored adr | $8,025,000 | – | 750,000 | +100.0% | 1.53% | – |
| MNTA | Buy | MOMENTA PHARMACEUTICALS INC | $7,892,000 | +74.0% | 400,000 | +14.3% | 1.50% | +30.0% |
| CHRS | New | COHERUS BIOSCIENCES INC | $7,742,000 | – | 430,000 | +100.0% | 1.47% | – |
| APLS | New | APELLIS PHARMACEUTICALS INCcall | $7,655,000 | – | 250,000 | +100.0% | 1.46% | – |
| KALV | Buy | KALVISTA PHARMACEUTICALS INC | $7,391,000 | +102.3% | 415,000 | +31.7% | 1.41% | +51.2% |
| MYOV | New | MYOVANT SCIENCES LTD | $6,984,000 | – | 450,000 | +100.0% | 1.33% | – |
| ISEE | New | IVERIC BIO INC | $6,435,000 | – | 750,000 | +100.0% | 1.22% | – |
| ARQL | New | ARQULE INC | $5,988,000 | – | 300,000 | +100.0% | 1.14% | – |
| FATE | Sell | FATE THERAPEUTICS INC | $5,382,000 | -1.0% | 275,000 | -21.4% | 1.02% | -26.0% |
| AMRN | New | AMARIN CORP PLCcall | $5,360,000 | – | 250,000 | +100.0% | 1.02% | – |
| APLS | New | APELLIS PHARMACEUTICALS INC | $5,359,000 | – | 175,000 | +100.0% | 1.02% | – |
| VRAY | Buy | VIEWRAY INC | $5,064,000 | +111.6% | 1,200,000 | +45.5% | 0.96% | +58.0% |
| FXF | Buy | INVESCO CURNCYSHS SWISS FRANswiss franc | $4,949,000 | +12.5% | 52,000 | +9.5% | 0.94% | -16.0% |
| INSM | New | INSMED INC | $4,776,000 | – | 200,000 | +100.0% | 0.91% | – |
| MRSN | New | MERSANA THERAPEUTICS INC | $4,584,000 | – | 800,000 | +100.0% | 0.87% | – |
| KNSA | New | KINIKSA PHARMACEUTICALS LTD | $3,871,000 | – | 350,000 | +100.0% | 0.74% | – |
| MIST | MILESTONE PHARMACEUTICALS IN | $3,762,000 | -14.2% | 235,000 | 0.0% | 0.72% | -35.9% | |
| ORTX | Sell | ORCHARD THERAPEUTICS PLCads | $3,085,000 | +6.9% | 224,359 | -7.7% | 0.59% | -20.1% |
| PHAS | New | PHASEBIO PHARMACEUTICALS INC | $2,750,000 | – | 450,000 | +100.0% | 0.52% | – |
| SELB | New | SELECTA BIOSCIENCES INC | $2,737,000 | – | 1,150,000 | +100.0% | 0.52% | – |
| GBT | New | GLOBAL BLOOD THERAPEUTICS IN | $2,655,000 | – | 33,400 | +100.0% | 0.51% | – |
| BHVN | Sell | BIOHAVEN PHARMACTL HLDG CO L | $2,178,000 | -85.1% | 40,000 | -88.6% | 0.42% | -88.8% |
| CHMA | Buy | CHIASMA INC | $2,108,000 | +11.4% | 425,000 | +11.1% | 0.40% | -16.8% |
| KDMN | Sell | KADMON HLDGS INC | $2,095,000 | -52.5% | 462,500 | -73.6% | 0.40% | -64.5% |
| PTGX | Buy | PROTAGONIST THERAPEUTICS INC | $1,939,000 | -35.4% | 275,000 | +10.0% | 0.37% | -51.8% |
| FXB | Sell | INVESCO CURNCYSHS BRIT PND Sbrit poun strl | $1,490,000 | -88.2% | 11,600 | -89.0% | 0.28% | -91.1% |
| KPTI | New | KARYOPHARM THERAPEUTICS INC | $968,000 | – | 50,500 | +100.0% | 0.18% | – |
| TGTX | New | TG THERAPEUTICS INC | $699,000 | – | 63,000 | +100.0% | 0.13% | – |
| ANAB | New | ANAPTYSBIO INC | $187,000 | – | 11,500 | +100.0% | 0.04% | – |
| SPPI | New | SPECTRUM PHARMACEUTICALS INC | $140,000 | – | 38,340 | +100.0% | 0.03% | – |
| DERM | Exit | DERMIRA INC | $0 | – | -42,500 | -100.0% | -0.07% | – |
| SLDB | Exit | SOLID BIOSCIENCES INC | $0 | – | -100,000 | -100.0% | -0.26% | – |
| EPZM | Exit | EPIZYME INC | $0 | – | -132,000 | -100.0% | -0.35% | – |
| AVRO | Exit | AVROBIO INC | $0 | – | -155,253 | -100.0% | -0.56% | – |
| CBAY | Exit | CYMABAY THERAPEUTICS INC | $0 | – | -440,000 | -100.0% | -0.57% | – |
| DRNA | Exit | DICERNA PHARMACEUTICALS INC | $0 | – | -235,000 | -100.0% | -0.86% | – |
| FIXX | Exit | HOMOLOGY MEDICINES INC | $0 | – | -225,000 | -100.0% | -1.04% | – |
| TPTX | Exit | TURNING POINT THERAPEUTICS I | $0 | – | -125,000 | -100.0% | -1.20% | – |
| ARGX | Exit | ARGENX SEsponsored adr | $0 | – | -50,000 | -100.0% | -1.45% | – |
| ATNX | Exit | ATHENEX INC | $0 | – | -522,500 | -100.0% | -1.62% | – |
| PCRX | Exit | PACIRA PHARMACEUTICALS INC | $0 | – | -250,000 | -100.0% | -2.42% | – |
| BMRN | Exit | BIOMARIN PHARMACEUTICAL INC | $0 | – | -185,000 | -100.0% | -3.18% | – |
| QQQ | Exit | INVESCO QQQ TRput | $0 | – | -75,000 | -100.0% | -3.61% | – |
| SRPT | Exit | SAREPTA THERAPEUTICS INCput | $0 | – | -200,000 | -100.0% | -3.84% | – |
| SAGE | Exit | SAGE THERAPEUTICS INC | $0 | – | -110,000 | -100.0% | -3.93% | – |
| IMMU | Exit | IMMUNOMEDICS INCcall | $0 | – | -1,201,000 | -100.0% | -4.06% | – |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR/A filed 2020-04-09
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| MIRATI THERAPEUTICS INC | 30 | Q3 2023 | 7.3% |
| ASCENDIS PHARMA A/S - ADR | 28 | Q3 2023 | 11.8% |
| BIOCRYST PHARMACEUTICALS INC | 25 | Q2 2023 | 2.4% |
| AMICUS THERAPEUTICS INC | 23 | Q3 2023 | 5.6% |
| SAREPTA THERAPEUTICS INC | 22 | Q3 2023 | 9.1% |
| SPDR SER TR | 20 | Q3 2022 | 16.9% |
| IOVANCE BIOTHERAPEUTICS INC | 18 | Q2 2023 | 5.5% |
| ROCKET PHARMACEUTICALS INC | 18 | Q2 2023 | 6.1% |
| SAGE THERAPEUTICS INC | 18 | Q1 2021 | 4.8% |
| IMMUNOMEDICS INC | 17 | Q2 2020 | 8.7% |
View Ghost Tree Capital, LLC's complete holdings history.
Latest filings
| Type | Filed |
|---|---|
| 13F-HR | 2024-02-14 |
| 13F-HR | 2023-11-14 |
| 13F-HR | 2023-08-14 |
| 13F-HR | 2023-05-15 |
| 13F-HR | 2023-02-14 |
| 13F-HR | 2022-11-14 |
| 13F-HR | 2022-08-15 |
| 13F-HR | 2022-05-16 |
| 13F-HR | 2022-02-16 |
| 13F-HR | 2021-11-15 |
View Ghost Tree Capital, LLC's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.